PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2016.46320174941153-1163Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Metastatic Breast Cancer Patients Treated with Aromatase InhibitorsKoung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Yu Jung Kim, Sae-Won Han, Eunyoung Kang, Eun-Kyu Kim, Kidong Kim, Jae Hong No, Wonshik Han, Dong-Young Noh, Maria Lee, Hee Seung Kim, Seock-Ah Im, Jee Hyun Kimhttp://www.e-crt.org/upload/pdf/crt-2016-463.pdf, http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2016.463, http://www.e-crt.org/upload/pdf/crt-2016-463.pdf
Clinical Breast Cancer10.3816/cbc.2007.n.002200776455-464Luteinizing Hormone-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Breast CancerSing-Huang Tan, Antonio C. Wolffhttps://api.elsevier.com/content/article/PII:S152682091170739X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S152682091170739X?httpAccept=text/plain
The Lancet10.1016/s0140-6736(07)60778-8200736995741711-1723Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trialshttps://api.elsevier.com/content/article/PII:S0140673607607788?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673607607788?httpAccept=text/plain
Annals of Medicine & Surgery10.1016/j.amsu.2022.103614202277Comparison of outcomes in patients with luminal type breast cancer treated with a gonadotropin-releasing hormone analog or bilateral salpingo-oophorectomy: A cohort retrospective studyDwi Ris Andriyanto, Prihantono, Salman Ardi Syamsu, Muhammad Ihwan Kusuma, Joko Hendarto, Indra, Nilam Smaradania, Elridho Sampepajung, Asrul Mappiwali, Muhammad Farukhttps://api.elsevier.com/content/article/PII:S2049080122003740?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2049080122003740?httpAccept=text/plain, https://journals.lww.com/10.1016/j.amsu.2022.103614
Surgery Today10.1007/s00595-013-0765-420134491678-1684A luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancerKimihiro Tanaka, Eriko Tokunaga, Nami Yamashita, Kenji Taketani, Sayuri Akiyoshi, Masaru Morita, Yoshihiko Maeharahttp://link.springer.com/content/pdf/10.1007/s00595-013-0765-4.pdf, http://link.springer.com/article/10.1007/s00595-013-0765-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00595-013-0765-4
Breast Diseases: A Year Book Quarterly10.1016/s1043-321x(08)80059-8200819185Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trialsG.F. Fleming, P. Francishttps://api.elsevier.com/content/article/PII:S1043321X08800598?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043321X08800598?httpAccept=text/plain
Frontiers in Oncology10.3389/fonc.2021.700722202111Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal WomenYen-Shen Lu, Andrea Wong, Hee-Jeong Kimhttps://www.frontiersin.org/articles/10.3389/fonc.2021.700722/full
Medical Council10.21518/2079-701x-2018-19-76-8420181976-84Tactics for minimizing risk of increasing estradiol against the background of aromatase inhibitors in combination with gonadotropin releasing hormone agonists in adjuvant therapy for breast cancer in premenopausal patients. Pilot study resultsI. B. Kononenko, A. V. Snegovoi, L. V. Manzyuk, E. I. Kovalenko, V. Yu. Selchukhttps://www.med-sovet.pro/jour/article/viewFile/2751/2703
Journal of Minimally Invasive Gynecology10.1016/j.jmig.2016.08.2052016237S85Underserved Premenopausal Women with Hormone Receptor Positive Breast Cancer Referred for Bilateral Salpingo-Oophorectomy – Is There a Benefit?J Klekman, A Kim, B Nguyen, A Moazzez, R Chlebowski, J Ozao-Choy, C Daupine, J Brothertonhttps://api.elsevier.com/content/article/PII:S1553465016303922?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1553465016303922?httpAccept=text/plain
European Journal of Cancer10.1016/j.ejca.2010.08.021201046162867-2869Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancerJonathan Krell, Edwina K. Ewart, Justin Stebbinghttps://api.elsevier.com/content/article/PII:S0959804910008440?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804910008440?httpAccept=text/plain